U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 68

  • Did you mean: g pad (160500 items)
1.
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results
Christiane Winkler, Florian Haupt, Martin Heigermoser, Jose Zapardiel‐Gonzalo, Jasmin Ohli, Theresa Faure, Evdokia Kalideri, Angela Hommel, Petrina Delivani, Reinhard Berner, Olga Kordonouri, Frank Roloff, Thekla von dem Berge, Karin Lange, Mariusz Oltarzewski, Ryszard Glab, Agnieszka Szypowska, Matthew D. Snape, Manu Vatish, John A. Todd, Helena E. Larsson, Anita Ramelius, Jeanette Å. Kördel, Kristina Casteels, Jasmin Paulus, Anette G. Ziegler, Ezio Bonifacio, the GPPAD Study Group
Pediatr Diabetes. 2019 Sep; 20(6): 720–727. Published online 2019 Jun 13. doi: 10.1111/pedi.12870
PMCID:
PMC6851563
ArticlePubReaderPDF–1.2MCite
2.
Primary prevention of beta-cell autoimmunity and type 1 diabetes – The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives
A.G. Ziegler, T. Danne, D.B. Dunger, R. Berner, R. Puff, W. Kiess, G. Agiostratidou, J.A. Todd, E. Bonifacio
Mol Metab. 2016 Apr; 5(4): 255–262. Published online 2016 Feb 22. doi: 10.1016/j.molmet.2016.02.003
PMCID:
PMC4811998
ArticlePubReaderPDF–853KCite
3.
Elevations in blood glucose before and after the appearance of islet autoantibodies in children
Katharina Warncke, Andreas Weiss, Peter Achenbach, Thekla von dem Berge, Reinhard Berner, Kristina Casteels, Lidia Groele, Konstantinos Hatzikotoulas, Angela Hommel, Olga Kordonouri, Helena Elding Larsson, Markus Lundgren, Benjamin A. Marcus, Matthew D. Snape, Agnieszka Szypowska, John A. Todd, Ezio Bonifacio, Anette-G. Ziegler, for the GPPAD and POInT Study Groups
J Clin Invest. 2022 Oct 17; 132(20): e162123. Published online 2022 Oct 17. doi: 10.1172/JCI162123
PMCID:
PMC9566912
ArticlePubReaderPDF–557KCite
4.
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
Anette-Gabriele Ziegler, Peter Achenbach, Reinhard Berner, Kristina Casteels, Thomas Danne, Melanie Gündert, Joerg Hasford, Verena Sophia Hoffmann, Olga Kordonouri, Karin Lange, Helena Elding Larsson, Markus Lundgren, Matthew D Snape, Agnieszka Szypowska, John A Todd, Ezio Bonifacio
BMJ Open. 2019; 9(6): e028578. Published online 2019 Jun 28. doi: 10.1136/bmjopen-2018-028578
PMCID:
PMC6609035
ArticlePubReaderPDF–613KCite
5.
Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol
Anette-Gabriele Ziegler, Stefanie Arnolds, Annika Kölln, Peter Achenbach, Reinhard Berner, Ezio Bonifacio, Kristina Casteels, Helena Elding Larsson, Melanie Gündert, Joerg Hasford, Olga Kordonouri, Markus Lundgren, Mariusz Oltarzewski, Marcin L Pekalski, Markus Pfirrmann, Matthew D Snape, Agnieszka Szypowska, John A Todd, GPPAD STUDY GROUP
BMJ Open. 2021; 11(11): e052449. Published online 2021 Nov 9. doi: 10.1136/bmjopen-2021-052449
PMCID:
PMC8578987
ArticlePubReaderPDF–472KCite
6.
Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials
Owen Martyn Bendor-Samuel, Tabitha Wishlade, Louise Willis, Parvinder Aley, Edward Choi, Rachel Craik, Yama Mujadidi, Ginny Mounce, Fenella Roseman, Arancha De La Horra Gozalo, James Bland, Nazia Taj, Ian Smith, Anette-Gabriele Ziegler, Ezio Bonifacio, Christiane Winkler, Florian Haupt, John A Todd, Laurent Servais, Matthew D Snape, Manu Vatish, the GPPAD Study Group
Arch Dis Child. 2023 Jan; 108(1): 26–30. Published online 2022 Sep 28. doi: 10.1136/archdischild-2022-324270
PMCID:
PMC9763160
ArticlePubReaderPDF–387KCite
7.
The countdown to type 1 diabetes: when, how and why does the clock start?
Anette-Gabriele Ziegler
Diabetologia. 2023; 66(7): 1169–1178. Published online 2023 May 26. doi: 10.1007/s00125-023-05927-2
PMCID:
PMC10212739
ArticlePubReaderPDF–909KCite
8.
Typ-1-Diabetes: Früherkennung und Ansätze zur Prävention: Update 2020
Benjamin A. Marcus, Peter Achenbach, Anette-Gabriele Ziegler
Diabetologe. 2020; 16(7): 654–661. German. Published online 2020 Aug 19. doi: 10.1007/s11428-020-00668-x
PMCID:
PMC7437100
ArticlePubReaderPDF–380KCite
9.
Utilizing Modular Biobanking Software in Different Types of Biobanking Activities
Laurent Jacotot, Mike Woodward, Axel de Montalier, Philippe Vaglio
Biopreserv Biobank. October 2022; 20(5): 417–422. Published online 2022 Oct 17. doi: 10.1089/bio.2022.0076
PMCID:
PMC9603250
ArticlePubReaderPDF–262KCite
10.
100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention
Anette-Gabriele Ziegler, Thomas Danne, Carolin Daniel, Ezio Bonifacio
Med (N Y) Author manuscript; available in PMC 2022 Jan 5.
Published in final edited form as: Med (N Y). 2021 Oct 8; 2(10): 1120–1137. Published online 2021 Sep 15. doi: 10.1016/j.medj.2021.08.003
PMCID:
PMC8730368
ArticlePubReaderPDF–1.3MCite
11.
Prevention of Type 1 Diabetes: Past Experiences and Future Opportunities
Przemysław Beik, Martyna Ciesielska, Maria Kucza, Alicja Kurczewska, Joanna Kuźmińska, Bartosz Maćkowiak, Elżbieta Niechciał
J Clin Med. 2020 Sep; 9(9): 2805. Published online 2020 Aug 30. doi: 10.3390/jcm9092805
PMCID:
PMC7563637
ArticlePubReaderPDF–538KCite
12.
The Willingness to Participate in Pediatric Type 1 Diabetes Studies
Sophie Heinke, Angela Hommel, Anja Loff, Reinhard Berner, Ezio Bonifacio, für das Freder1k- & POInT-Studienteam
Dtsch Arztebl Int. 2022 Jul; 119(27-28): 488–489. Published online 2022 Jul 11. doi: 10.3238/arztebl.m2022.0171
PMCID:
PMC9664987
ArticlePubReaderPDF–195KCite
13.
The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness
Maxwell J. Fyvie, Kathleen M. Gillespie
Front Immunol. 2023; 14: 1158278. Published online 2023 May 15. doi: 10.3389/fimmu.2023.1158278
PMCID:
PMC10225507
ArticlePubReaderPDF–1.1MCite
14.
Oral delivery of peptide therapeutics in infants: Challenges and opportunities
John P. Gleeson, Katherine C. Fein, Kathryn A. Whitehead
Adv Drug Deliv Rev. Author manuscript; available in PMC 2021 Jun 5.
Published in final edited form as: Adv Drug Deliv Rev. 2021 Jun; 173: 112–124. Published online 2021 Mar 25. doi: 10.1016/j.addr.2021.03.011
PMCID:
PMC8178217
ArticlePubReaderPDF–765KCite
15.
A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children
Markus Hippich, Lisa Holthaus, Robin Assfalg, Jose Zapardiel-Gonzalo, Heidi Kapfelsperger, Martin Heigermoser, Florian Haupt, Dominik A. Ewald, Tiziana C. Welzhofer, Benjamin A. Marcus, Susanne Heck, Annika Koelln, Joanna Stock, Franziska Voss, Massimiliano Secchi, Lorenzo Piemonti, Kathrin de la Rosa, Ulrike Protzer, Merle Boehmer, Peter Achenbach, Vito Lampasona, Ezio Bonifacio, Anette-Gabriele Ziegler
Med (N Y) 2021 Feb 12; 2(2): 149–163.e4. Published online 2020 Oct 29. doi: 10.1016/j.medj.2020.10.003
PMCID:
PMC7598360
ArticlePubReaderPDF–12MCite
16.
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective
Emily K. Sims, Rachel E.J. Besser, Colin Dayan, Cristy Geno Rasmussen, Carla Greenbaum, Kurt J. Griffin, William Hagopian, Mikael Knip, Anna E. Long, Frank Martin, Chantal Mathieu, Marian Rewers, Andrea K. Steck, John M. Wentworth, Stephen S. Rich, Olga Kordonouri, Anette-Gabriele Ziegler, Kevan C. Herold, for the NIDDK Type 1 Diabetes TrialNet Study Group
Diabetes. 2022 Apr; 71(4): 610–623. Published online 2022 Mar 21. doi: 10.2337/dbi20-0054
PMCID:
PMC9114719
ArticlePubReaderPDF–6.2MCite
17.
Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route
Johnny Ludvigsson
Int J Mol Sci. 2020 Mar; 21(5): 1598. Published online 2020 Feb 26. doi: 10.3390/ijms21051598
PMCID:
PMC7084272
ArticlePubReaderPDF–679KCite
18.
Utility of genetic risk scores in type 1 diabetes
Amber M. Luckett, Michael N. Weedon, Gareth Hawkes, R. David Leslie, Richard A. Oram, Struan F. A. Grant
Diabetologia. 2023; 66(9): 1589–1600. Published online 2023 Jul 13. doi: 10.1007/s00125-023-05955-y
PMCID:
PMC10390619
ArticlePubReaderPDF–1.4MCite
19.
Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study
Mohamed Ghalwash, Vibha Anand, Olivia Lou, Frank Martin, Marian Rewers, Anette-G Ziegler, Jorma Toppari, William A Hagopian, Riitta Veijola, Type 1 Diabetes Intelligence Study Group
Lancet Child Adolesc Health. Author manuscript; available in PMC 2023 Apr 1.
Published in final edited form as: Lancet Child Adolesc Health. 2023 Apr; 7(4): 261–268. Published online 2023 Jan 18. doi: 10.1016/S2352-4642(22)00350-9
PMCID:
PMC10038928
ArticlePubReaderPDF–668KCite
20.
Type 1 diabetes mellitus and its oral tolerance therapy
Rui-Feng Mao, Ying-Ying Chen, Ji Zhang, Xin Chang, Ye-Fu Wang
World J Diabetes. 2020 Oct 15; 11(10): 400–415. Published online 2020 Oct 15. doi: 10.4239/wjd.v11.i10.400
PMCID:
PMC7582116
ArticlePubReaderPDF–4.8MCite
  • Did you mean: g pad (160500 items)

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Search details

See more...

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center